PMV Pharmaceuticals, Inc. (PMVP) Tops Q2 EPS by 33c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q2 EPS of ($0.02), $0.33 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Reddit to join S&P 500 index on Aug. 18, shares leap
• Cineverse (CNVS) PT Raised to $14 at Benchmark on Revenue, Earnings Beat